Pfizer/BioNTech Say Three Shots Generate Strong Immune Response in Kids Under 5
Pfizer and BioNTech said on Monday that three doses of their COVID-19 vaccine produced a strong immune response in children under the age of five in their clinical trial. Pfizer and BioNTech said they found that the vaccine was up …